

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.19851657 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.19851657 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.74207991 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.74207991 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.57950392 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.57950392 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.56998240 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 4.33539309 |
| 9 | cysteine metabolic process (GO:0006534) | 4.32188385 |
| 10 | COPII vesicle coating (GO:0048208) | 4.25286526 |
| 11 | protein retention in ER lumen (GO:0006621) | 4.15072815 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.05123019 |
| 13 | angiotensin maturation (GO:0002003) | 3.95012510 |
| 14 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81612934 |
| 15 | lysine metabolic process (GO:0006553) | 3.81362453 |
| 16 | lysine catabolic process (GO:0006554) | 3.81362453 |
| 17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.71166721 |
| 18 | glycosphingolipid catabolic process (GO:0046479) | 3.64130900 |
| 19 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.62956547 |
| 20 | glycolipid catabolic process (GO:0019377) | 3.60361927 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.54386043 |
| 22 | intestinal cholesterol absorption (GO:0030299) | 3.52316197 |
| 23 | exocrine pancreas development (GO:0031017) | 3.49612654 |
| 24 | regulation of cholesterol homeostasis (GO:2000188) | 3.49271458 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 3.48798360 |
| 26 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.46042457 |
| 27 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.45821664 |
| 28 | intestinal absorption (GO:0050892) | 3.45494585 |
| 29 | 4-hydroxyproline metabolic process (GO:0019471) | 3.43268316 |
| 30 | cell adhesion mediated by integrin (GO:0033627) | 3.35214593 |
| 31 | desmosome organization (GO:0002934) | 3.35000855 |
| 32 | drug transmembrane transport (GO:0006855) | 3.32828929 |
| 33 | negative regulation of protein activation cascade (GO:2000258) | 3.31771590 |
| 34 | positive regulation of nuclease activity (GO:0032075) | 3.28613629 |
| 35 | negative regulation of complement activation (GO:0045916) | 3.27973898 |
| 36 | L-serine transport (GO:0015825) | 3.26886592 |
| 37 | protein carboxylation (GO:0018214) | 3.26101190 |
| 38 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.26101190 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.23288720 |
| 40 | homocysteine metabolic process (GO:0050667) | 3.21642910 |
| 41 | bile acid biosynthetic process (GO:0006699) | 3.21009878 |
| 42 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.18620407 |
| 43 | glyoxylate metabolic process (GO:0046487) | 3.18364818 |
| 44 | reverse cholesterol transport (GO:0043691) | 3.16608278 |
| 45 | cellular modified amino acid catabolic process (GO:0042219) | 3.15028041 |
| 46 | valine metabolic process (GO:0006573) | 3.12727315 |
| 47 | phospholipid efflux (GO:0033700) | 3.12610029 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.10317867 |
| 49 | cellular glucuronidation (GO:0052695) | 3.08059667 |
| 50 | negative regulation of humoral immune response (GO:0002921) | 3.07157200 |
| 51 | membrane budding (GO:0006900) | 3.06403457 |
| 52 | bile acid metabolic process (GO:0008206) | 3.06247586 |
| 53 | ceramide catabolic process (GO:0046514) | 3.06196063 |
| 54 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.04217351 |
| 55 | regulation of protein activation cascade (GO:2000257) | 3.04164368 |
| 56 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.03293073 |
| 57 | fatty acid beta-oxidation (GO:0006635) | 2.99901564 |
| 58 | high-density lipoprotein particle remodeling (GO:0034375) | 2.99821790 |
| 59 | glucuronate metabolic process (GO:0019585) | 2.99687224 |
| 60 | uronic acid metabolic process (GO:0006063) | 2.99687224 |
| 61 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.99005357 |
| 62 | negative regulation of sterol transport (GO:0032372) | 2.97380468 |
| 63 | negative regulation of cholesterol transport (GO:0032375) | 2.97380468 |
| 64 | fatty acid oxidation (GO:0019395) | 2.97075316 |
| 65 | NADH metabolic process (GO:0006734) | 2.95501438 |
| 66 | amyloid precursor protein catabolic process (GO:0042987) | 2.95295777 |
| 67 | glycoside metabolic process (GO:0016137) | 2.94861097 |
| 68 | regulation of complement activation (GO:0030449) | 2.94327833 |
| 69 | cellular response to unfolded protein (GO:0034620) | 2.92856526 |
| 70 | membrane protein ectodomain proteolysis (GO:0006509) | 2.92702322 |
| 71 | vesicle coating (GO:0006901) | 2.91908817 |
| 72 | short-chain fatty acid metabolic process (GO:0046459) | 2.91630434 |
| 73 | regulation of nuclease activity (GO:0032069) | 2.91317155 |
| 74 | lipoprotein metabolic process (GO:0042157) | 2.91196333 |
| 75 | lipid oxidation (GO:0034440) | 2.91186180 |
| 76 | signal peptide processing (GO:0006465) | 2.91002627 |
| 77 | complement activation, alternative pathway (GO:0006957) | 2.89779222 |
| 78 | peptide catabolic process (GO:0043171) | 2.89500215 |
| 79 | transcytosis (GO:0045056) | 2.87791790 |
| 80 | peptide hormone processing (GO:0016486) | 2.87619655 |
| 81 | positive regulation of glycolytic process (GO:0045821) | 2.87366833 |
| 82 | ER-nucleus signaling pathway (GO:0006984) | 2.86878228 |
| 83 | bile acid and bile salt transport (GO:0015721) | 2.86709435 |
| 84 | aspartate family amino acid catabolic process (GO:0009068) | 2.84898570 |
| 85 | intestinal epithelial cell development (GO:0060576) | 2.83453701 |
| 86 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.82761883 |
| 87 | fatty acid catabolic process (GO:0009062) | 2.82352928 |
| 88 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.81491378 |
| 89 | sequestering of metal ion (GO:0051238) | 2.81348552 |
| 90 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.81078819 |
| 91 | sphingolipid catabolic process (GO:0030149) | 2.80113427 |
| 92 | endocrine pancreas development (GO:0031018) | 2.79773629 |
| 93 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.79326470 |
| 94 | membrane lipid catabolic process (GO:0046466) | 2.79251465 |
| 95 | sphingomyelin metabolic process (GO:0006684) | 2.79064140 |
| 96 | tricarboxylic acid metabolic process (GO:0072350) | 2.79036364 |
| 97 | regulation of fibrinolysis (GO:0051917) | 2.78689233 |
| 98 | lung epithelium development (GO:0060428) | 2.78291962 |
| 99 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.77968642 |
| 100 | cellular response to topologically incorrect protein (GO:0035967) | 2.77907974 |
| 101 | cellular ketone body metabolic process (GO:0046950) | 2.77900833 |
| 102 | peptidyl-asparagine modification (GO:0018196) | 2.77755127 |
| 103 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.77735221 |
| 104 | amino-acid betaine metabolic process (GO:0006577) | 2.77429085 |
| 105 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.75900599 |
| 106 | oligosaccharide biosynthetic process (GO:0009312) | 2.75545878 |
| 107 | keratan sulfate catabolic process (GO:0042340) | 2.74706006 |
| 108 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.73875786 |
| 109 | protein maturation by protein folding (GO:0022417) | 2.73853049 |
| 110 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.73588535 |
| 111 | plasma lipoprotein particle clearance (GO:0034381) | 2.73522395 |
| 112 | regulation of triglyceride catabolic process (GO:0010896) | 2.73141905 |
| 113 | kynurenine metabolic process (GO:0070189) | 2.72279387 |
| 114 | triglyceride homeostasis (GO:0070328) | 2.72032502 |
| 115 | acylglycerol homeostasis (GO:0055090) | 2.72032502 |
| 116 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.71733849 |
| 117 | urea metabolic process (GO:0019627) | 2.71726383 |
| 118 | urea cycle (GO:0000050) | 2.71726383 |
| 119 | primary alcohol catabolic process (GO:0034310) | 2.71286566 |
| 120 | drug transport (GO:0015893) | 2.70535570 |
| 121 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.70081351 |
| 122 | serine transport (GO:0032329) | 2.70051129 |
| 123 | response to mercury ion (GO:0046689) | 2.69502522 |
| 124 | apoptotic cell clearance (GO:0043277) | 2.68487560 |
| 125 | ethanol oxidation (GO:0006069) | 2.67590433 |
| 126 | protein-lipid complex assembly (GO:0065005) | 2.67572821 |
| 127 | protein N-linked glycosylation (GO:0006487) | 2.67369318 |
| 128 | 2-oxoglutarate metabolic process (GO:0006103) | 2.67293900 |
| 129 | glutamate metabolic process (GO:0006536) | 2.66891089 |
| 130 | nitrogen cycle metabolic process (GO:0071941) | 2.65667159 |
| 131 | lipoprotein transport (GO:0042953) | 2.65495086 |
| 132 | regulation of cholesterol metabolic process (GO:0090181) | 2.64821352 |
| 133 | drug catabolic process (GO:0042737) | 2.64104014 |
| 134 | plasma lipoprotein particle remodeling (GO:0034369) | 2.63304304 |
| 135 | protein-lipid complex remodeling (GO:0034368) | 2.63304304 |
| 136 | macromolecular complex remodeling (GO:0034367) | 2.63304304 |
| 137 | oligosaccharide catabolic process (GO:0009313) | 2.63155142 |
| 138 | cellular copper ion homeostasis (GO:0006878) | 2.62369113 |
| 139 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.62294999 |
| 140 | toxin metabolic process (GO:0009404) | 2.62218806 |
| 141 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.61470424 |
| 142 | monocarboxylic acid catabolic process (GO:0072329) | 2.61318034 |
| 143 | protein localization to endosome (GO:0036010) | 2.61001105 |
| 144 | regulation of cholesterol esterification (GO:0010872) | 2.59258903 |
| 145 | beta-amyloid metabolic process (GO:0050435) | 2.59180908 |
| 146 | response to endoplasmic reticulum stress (GO:0034976) | 2.58703427 |
| 147 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.58122440 |
| 148 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.57977575 |
| 149 | iron ion import (GO:0097286) | 2.57588004 |
| 150 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.56537471 |
| 151 | vitamin transmembrane transport (GO:0035461) | 2.56368314 |
| 152 | low-density lipoprotein particle clearance (GO:0034383) | 2.55617272 |
| 153 | epoxygenase P450 pathway (GO:0019373) | 2.55590865 |
| 154 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.55221696 |
| 155 | plasma lipoprotein particle assembly (GO:0034377) | 2.54770435 |
| 156 | ethanol metabolic process (GO:0006067) | 2.52897727 |
| 157 | cholesterol efflux (GO:0033344) | 2.52667044 |
| 158 | hemidesmosome assembly (GO:0031581) | 2.51733427 |
| 159 | very long-chain fatty acid metabolic process (GO:0000038) | 2.51115720 |
| 160 | zinc ion transport (GO:0006829) | 2.50565818 |
| 161 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.45827147 |
| 162 | polyketide metabolic process (GO:0030638) | 2.43384071 |
| 163 | doxorubicin metabolic process (GO:0044598) | 2.43384071 |
| 164 | daunorubicin metabolic process (GO:0044597) | 2.43384071 |
| 165 | nucleotide transmembrane transport (GO:1901679) | 2.41339491 |
| 166 | amyloid precursor protein metabolic process (GO:0042982) | 2.39736984 |
| 167 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.39522262 |
| 168 | mRNA modification (GO:0016556) | 2.37445543 |
| 169 | phospholipid homeostasis (GO:0055091) | 2.36664767 |
| 170 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.36373256 |
| 171 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.35536981 |
| 172 | nucleotide-sugar metabolic process (GO:0009225) | 2.34597743 |
| 173 | polyol transport (GO:0015791) | 2.32918206 |
| 174 | regulation of apoptotic cell clearance (GO:2000425) | 2.32701970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.16598017 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.26914913 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.63553899 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.39779141 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.75705039 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.66242945 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.65146819 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.13829983 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.08578837 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.96799321 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.93013143 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52963859 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.44856509 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.44296042 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.37492188 |
| 16 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.31412974 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26299823 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.13657914 |
| 19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.10776074 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.09285069 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.99013969 |
| 22 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.97330933 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.96201611 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92852168 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.87317693 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.85414713 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83290119 |
| 28 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.82858369 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.82001117 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.78319149 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.68009032 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66927849 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.66683040 |
| 34 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63049227 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62325771 |
| 36 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.57737775 |
| 37 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56393824 |
| 38 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.50452764 |
| 39 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49970641 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49292645 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.47359695 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.47359695 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44262009 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.41813234 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.41711177 |
| 46 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40306522 |
| 47 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.39390566 |
| 48 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.36883960 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36183870 |
| 50 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33822968 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32803803 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29773124 |
| 53 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29475964 |
| 54 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27559193 |
| 55 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27368723 |
| 56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27266388 |
| 57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26305902 |
| 58 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25311148 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24972029 |
| 60 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24795501 |
| 61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24281143 |
| 62 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23938377 |
| 63 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.23937511 |
| 64 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20792778 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18860529 |
| 66 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.18787205 |
| 67 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.17719265 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14509342 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.14195618 |
| 70 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.12996032 |
| 71 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12376434 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10482222 |
| 73 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.10383689 |
| 74 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09521774 |
| 75 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09364701 |
| 76 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08179082 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07748960 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05833024 |
| 79 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04626345 |
| 80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04458526 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03674761 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03672516 |
| 83 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03049668 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01346439 |
| 85 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01296685 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01296685 |
| 87 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.00799544 |
| 88 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.00722660 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00160245 |
| 90 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99136308 |
| 91 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.98596354 |
| 92 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98542273 |
| 93 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97648347 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97261332 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96882576 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96222022 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96126784 |
| 98 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94741676 |
| 99 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93867984 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93723055 |
| 101 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.92864254 |
| 102 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92552358 |
| 103 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.91442435 |
| 104 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.91254803 |
| 105 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90661569 |
| 106 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.90545310 |
| 107 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90278434 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90036327 |
| 109 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90011329 |
| 110 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87678006 |
| 111 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.86917334 |
| 112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84930569 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84816054 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84141973 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83574345 |
| 116 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.83189760 |
| 117 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.82214280 |
| 118 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82036834 |
| 119 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81698740 |
| 120 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81128069 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81120328 |
| 122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79453734 |
| 123 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79410161 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.77836883 |
| 125 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77034742 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75744699 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.75458831 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.72302137 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.70291603 |
| 130 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69797486 |
| 131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68000132 |
| 132 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.67852158 |
| 133 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67384904 |
| 134 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67384904 |
| 135 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.66468756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.23106451 |
| 2 | MP0005360_urolithiasis | 4.69474132 |
| 3 | MP0005365_abnormal_bile_salt | 4.28835400 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.63524995 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.16012392 |
| 6 | MP0003195_calcinosis | 3.10269839 |
| 7 | MP0001666_abnormal_nutrient_absorption | 2.96226620 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 2.77040871 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.71010574 |
| 10 | MP0003252_abnormal_bile_duct | 2.67999797 |
| 11 | MP0009840_abnormal_foam_cell | 2.46659615 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.41773820 |
| 13 | MP0003283_abnormal_digestive_organ | 2.32060039 |
| 14 | MP0004782_abnormal_surfactant_physiolog | 2.31979407 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.31716576 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.26693325 |
| 17 | MP0003941_abnormal_skin_development | 2.19597287 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.17469426 |
| 19 | MP0004043_abnormal_pH_regulation | 2.15403380 |
| 20 | MP0005332_abnormal_amino_acid | 2.11810457 |
| 21 | MP0006054_spinal_hemorrhage | 2.10974497 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.05657624 |
| 23 | MP0002009_preneoplasia | 2.04761452 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 2.01138800 |
| 25 | MP0005083_abnormal_biliary_tract | 1.99033751 |
| 26 | MP0005220_abnormal_exocrine_pancreas | 1.97066320 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.94911015 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.90155334 |
| 29 | MP0009384_cardiac_valve_regurgitation | 1.90006398 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.87207135 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.84661302 |
| 32 | MP0008260_abnormal_autophagy | 1.77366607 |
| 33 | MP0002796_impaired_skin_barrier | 1.74850299 |
| 34 | MP0003868_abnormal_feces_composition | 1.71493293 |
| 35 | MP0008004_abnormal_stomach_pH | 1.71277846 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.69871635 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.66466337 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.65165810 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.60085366 |
| 40 | MP0004272_abnormal_basement_membrane | 1.56832036 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.53026104 |
| 42 | MP0000462_abnormal_digestive_system | 1.52877818 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.52172170 |
| 44 | MP0001944_abnormal_pancreas_morphology | 1.45942437 |
| 45 | MP0000609_abnormal_liver_physiology | 1.44661993 |
| 46 | MP0003329_amyloid_beta_deposits | 1.40162200 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.39602287 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.37540136 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.34797693 |
| 50 | MP0002098_abnormal_vibrissa_morphology | 1.34587610 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.32808936 |
| 52 | MP0006082_CNS_inflammation | 1.31350216 |
| 53 | MP0001765_abnormal_ion_homeostasis | 1.29810083 |
| 54 | MP0000604_amyloidosis | 1.29076159 |
| 55 | MP0002254_reproductive_system_inflammat | 1.25439463 |
| 56 | MP0001756_abnormal_urination | 1.22830756 |
| 57 | MP0005275_abnormal_skin_tensile | 1.21910061 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.18818961 |
| 59 | MP0002896_abnormal_bone_mineralization | 1.18481075 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.18459636 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.17161863 |
| 62 | MP0002006_tumorigenesis | 1.12565132 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.12397753 |
| 64 | MP0002090_abnormal_vision | 1.11638370 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.10245335 |
| 66 | MP0001958_emphysema | 1.09971609 |
| 67 | MP0005409_darkened_coat_color | 1.08539534 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 1.07866200 |
| 69 | MP0001661_extended_life_span | 1.07388744 |
| 70 | MP0001216_abnormal_epidermal_layer | 1.06342336 |
| 71 | MP0000003_abnormal_adipose_tissue | 1.06221428 |
| 72 | MP0002693_abnormal_pancreas_physiology | 1.04975666 |
| 73 | MP0001915_intracranial_hemorrhage | 1.03570181 |
| 74 | MP0005248_abnormal_Harderian_gland | 1.01319791 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.01102306 |
| 76 | MP0005501_abnormal_skin_physiology | 0.99265717 |
| 77 | MP0005408_hypopigmentation | 0.95158677 |
| 78 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94707558 |
| 79 | MP0009697_abnormal_copulation | 0.92099787 |
| 80 | MP0000383_abnormal_hair_follicle | 0.91841178 |
| 81 | MP0001764_abnormal_homeostasis | 0.90914495 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89438362 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.89069038 |
| 84 | MP0000377_abnormal_hair_follicle | 0.88191033 |
| 85 | MP0000537_abnormal_urethra_morphology | 0.87038506 |
| 86 | MP0000627_abnormal_mammary_gland | 0.84541403 |
| 87 | MP0005164_abnormal_response_to | 0.84134917 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.83909920 |
| 89 | MP0003724_increased_susceptibility_to | 0.82613080 |
| 90 | MP0000490_abnormal_crypts_of | 0.82005931 |
| 91 | MP0004130_abnormal_muscle_cell | 0.81998943 |
| 92 | MP0002928_abnormal_bile_duct | 0.81697540 |
| 93 | MP0009053_abnormal_anal_canal | 0.80773001 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.80594339 |
| 95 | MP0005310_abnormal_salivary_gland | 0.80572931 |
| 96 | MP0000477_abnormal_intestine_morphology | 0.79379632 |
| 97 | MP0002295_abnormal_pulmonary_circulatio | 0.79335540 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.79037229 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.76358724 |
| 100 | MP0000566_synostosis | 0.76310399 |
| 101 | MP0008961_abnormal_basal_metabolism | 0.76093541 |
| 102 | MP0010352_gastrointestinal_tract_polyps | 0.75428928 |
| 103 | MP0005381_digestive/alimentary_phenotyp | 0.75250402 |
| 104 | MP0002168_other_aberrant_phenotype | 0.74446522 |
| 105 | MP0005375_adipose_tissue_phenotype | 0.74370174 |
| 106 | MP0010678_abnormal_skin_adnexa | 0.74301763 |
| 107 | MP0000538_abnormal_urinary_bladder | 0.72714127 |
| 108 | MP0001299_abnormal_eye_distance/ | 0.71416631 |
| 109 | MP0000598_abnormal_liver_morphology | 0.71256279 |
| 110 | MP0005023_abnormal_wound_healing | 0.70899398 |
| 111 | MP0004883_abnormal_blood_vessel | 0.70527670 |
| 112 | MP0001873_stomach_inflammation | 0.70358626 |
| 113 | MP0003186_abnormal_redox_activity | 0.70352760 |
| 114 | MP0005367_renal/urinary_system_phenotyp | 0.69577566 |
| 115 | MP0000516_abnormal_urinary_system | 0.69577566 |
| 116 | MP0003448_altered_tumor_morphology | 0.68882391 |
| 117 | MP0001879_abnormal_lymphatic_vessel | 0.67995197 |
| 118 | MP0005166_decreased_susceptibility_to | 0.67990772 |
| 119 | MP0001664_abnormal_digestion | 0.67647607 |
| 120 | MP0003959_abnormal_lean_body | 0.67210344 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.66746773 |
| 122 | MP0001270_distended_abdomen | 0.66032131 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.65244188 |
| 124 | MP0009642_abnormal_blood_homeostasis | 0.65217931 |
| 125 | MP0003890_abnormal_embryonic-extraembry | 0.65077349 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.64952444 |
| 127 | MP0002060_abnormal_skin_morphology | 0.63943689 |
| 128 | MP0000858_altered_metastatic_potential | 0.63936664 |
| 129 | MP0000613_abnormal_salivary_gland | 0.63765574 |
| 130 | MP0000639_abnormal_adrenal_gland | 0.62576452 |
| 131 | MP0008469_abnormal_protein_level | 0.62446857 |
| 132 | MP0005379_endocrine/exocrine_gland_phen | 0.61444052 |
| 133 | MP0003091_abnormal_cell_migration | 0.61063337 |
| 134 | MP0005165_increased_susceptibility_to | 0.60886688 |
| 135 | MP0003075_altered_response_to | 0.60608998 |
| 136 | MP0009785_altered_susceptibility_to | 0.59858199 |
| 137 | MP0000163_abnormal_cartilage_morphology | 0.59352902 |
| 138 | MP0001881_abnormal_mammary_gland | 0.59060181 |
| 139 | MP0005257_abnormal_intraocular_pressure | 0.58667555 |
| 140 | MP0003453_abnormal_keratinocyte_physiol | 0.57978304 |
| 141 | MP0005451_abnormal_body_composition | 0.57644264 |
| 142 | MP0002133_abnormal_respiratory_system | 0.57620367 |
| 143 | MP0005388_respiratory_system_phenotype | 0.57620367 |
| 144 | MP0002971_abnormal_brown_adipose | 0.56479489 |
| 145 | MP0002419_abnormal_innate_immunity | 0.56321220 |
| 146 | MP0004957_abnormal_blastocyst_morpholog | 0.56263926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.81035806 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.52158005 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.40830382 |
| 4 | Xanthomatosis (HP:0000991) | 4.04642672 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.99829003 |
| 6 | Ketoacidosis (HP:0001993) | 3.98286117 |
| 7 | Hypoglycemic seizures (HP:0002173) | 3.91803074 |
| 8 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.82505550 |
| 9 | Ketosis (HP:0001946) | 3.54306809 |
| 10 | Loss of speech (HP:0002371) | 3.39395834 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.38465937 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.20218458 |
| 13 | Abnormality of the intrinsic pathway (HP:0010989) | 3.19724920 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.18278528 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15893983 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15893983 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15893983 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14542010 |
| 19 | Fat malabsorption (HP:0002630) | 3.11954012 |
| 20 | Symptomatic seizures (HP:0011145) | 3.11399970 |
| 21 | Tetraparesis (HP:0002273) | 3.10027959 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.08375503 |
| 23 | Gout (HP:0001997) | 2.98199600 |
| 24 | Late onset (HP:0003584) | 2.90865561 |
| 25 | Complement deficiency (HP:0004431) | 2.89248858 |
| 26 | Dysostosis multiplex (HP:0000943) | 2.87649648 |
| 27 | Hyperglycemia (HP:0003074) | 2.80094200 |
| 28 | Glomerulonephritis (HP:0000099) | 2.80039843 |
| 29 | Mucopolysacchariduria (HP:0008155) | 2.77044622 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.77044622 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.75908397 |
| 32 | Hyperammonemia (HP:0001987) | 2.72806703 |
| 33 | Abnormality of purine metabolism (HP:0004352) | 2.63735992 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.62362351 |
| 35 | Flat acetabular roof (HP:0003180) | 2.58343552 |
| 36 | Hyperlipoproteinemia (HP:0010980) | 2.57959622 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.57803875 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 2.53960785 |
| 39 | Abdominal distention (HP:0003270) | 2.53791905 |
| 40 | Osteolytic defects of the hand bones (HP:0009699) | 2.53396823 |
| 41 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.53396823 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 2.52216418 |
| 43 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.50710425 |
| 44 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.50710425 |
| 45 | Papillary thyroid carcinoma (HP:0002895) | 2.49614706 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.47281249 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46821906 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46821906 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46821906 |
| 50 | Protuberant abdomen (HP:0001538) | 2.46048080 |
| 51 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.45498905 |
| 52 | Lower limb hyperreflexia (HP:0002395) | 2.43485169 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.43399575 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.43137118 |
| 55 | Hyperglycinuria (HP:0003108) | 2.41488967 |
| 56 | Abnormality of glycine metabolism (HP:0010895) | 2.35469850 |
| 57 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.35469850 |
| 58 | Hydroxyprolinuria (HP:0003080) | 2.34214072 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.34214072 |
| 60 | Skin nodule (HP:0200036) | 2.34164570 |
| 61 | Esophageal varix (HP:0002040) | 2.33910637 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.33579932 |
| 63 | Malnutrition (HP:0004395) | 2.33475052 |
| 64 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31972120 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.31804810 |
| 66 | Epidermoid cyst (HP:0200040) | 2.25753149 |
| 67 | Protrusio acetabuli (HP:0003179) | 2.25382584 |
| 68 | Aortic aneurysm (HP:0004942) | 2.25225233 |
| 69 | Hyperactive renin-angiotensin system (HP:0000841) | 2.24109356 |
| 70 | Abnormality of complement system (HP:0005339) | 2.24102259 |
| 71 | Steatorrhea (HP:0002570) | 2.23929303 |
| 72 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.23897350 |
| 73 | Periodontitis (HP:0000704) | 2.21720055 |
| 74 | Back pain (HP:0003418) | 2.21493293 |
| 75 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.19842374 |
| 76 | Premature rupture of membranes (HP:0001788) | 2.18193725 |
| 77 | Right ventricular cardiomyopathy (HP:0011663) | 2.16337579 |
| 78 | Aortic dissection (HP:0002647) | 2.14787633 |
| 79 | Disinhibition (HP:0000734) | 2.14578227 |
| 80 | Chronic diarrhea (HP:0002028) | 2.13835540 |
| 81 | Alopecia of scalp (HP:0002293) | 2.13599452 |
| 82 | Insulin resistance (HP:0000855) | 2.10056187 |
| 83 | Cervical subluxation (HP:0003308) | 2.09570686 |
| 84 | Abnormal foot bone ossification (HP:0010675) | 2.09106011 |
| 85 | Neurofibrillary tangles (HP:0002185) | 2.08668243 |
| 86 | Proximal tubulopathy (HP:0000114) | 2.05032611 |
| 87 | Amyloidosis (HP:0011034) | 2.02956983 |
| 88 | Myocardial infarction (HP:0001658) | 2.02614822 |
| 89 | Curly hair (HP:0002212) | 2.00314633 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.00151565 |
| 91 | Vertebral compression fractures (HP:0002953) | 1.99566637 |
| 92 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.98895825 |
| 93 | Aneurysm (HP:0002617) | 1.98735680 |
| 94 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.96118423 |
| 95 | Plantar hyperkeratosis (HP:0007556) | 1.95359511 |
| 96 | Beaking of vertebral bodies (HP:0004568) | 1.94375888 |
| 97 | Hyperglycinemia (HP:0002154) | 1.94369540 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 1.94341719 |
| 99 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.93717841 |
| 100 | Abnormality of chloride homeostasis (HP:0011422) | 1.93627199 |
| 101 | Facial shape deformation (HP:0011334) | 1.93286150 |
| 102 | Potter facies (HP:0002009) | 1.93286150 |
| 103 | Abnormal protein glycosylation (HP:0012346) | 1.92906562 |
| 104 | Abnormal glycosylation (HP:0012345) | 1.92906562 |
| 105 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92906562 |
| 106 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92906562 |
| 107 | Gingival bleeding (HP:0000225) | 1.92506817 |
| 108 | Abnormal tarsal ossification (HP:0008369) | 1.89915430 |
| 109 | Retinal atrophy (HP:0001105) | 1.88996083 |
| 110 | Hyperbilirubinemia (HP:0002904) | 1.88950598 |
| 111 | Abnormality of nucleobase metabolism (HP:0010932) | 1.88067148 |
| 112 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.87857278 |
| 113 | Abnormality of macrophages (HP:0004311) | 1.87740873 |
| 114 | Pili torti (HP:0003777) | 1.87105428 |
| 115 | Eczematoid dermatitis (HP:0000976) | 1.86601977 |
| 116 | Irritability (HP:0000737) | 1.85620546 |
| 117 | Cerebral inclusion bodies (HP:0100314) | 1.85289203 |
| 118 | Termporal pattern (HP:0011008) | 1.84797556 |
| 119 | Insidious onset (HP:0003587) | 1.84797556 |
| 120 | Acanthocytosis (HP:0001927) | 1.84237806 |
| 121 | Palmar hyperkeratosis (HP:0010765) | 1.83157966 |
| 122 | Patchy hypopigmentation of hair (HP:0011365) | 1.82789620 |
| 123 | Cerebral aneurysm (HP:0004944) | 1.82126437 |
| 124 | Increased purine levels (HP:0004368) | 1.82031150 |
| 125 | Hyperuricemia (HP:0002149) | 1.82031150 |
| 126 | Abnormal biliary tract morphology (HP:0012440) | 1.82002733 |
| 127 | Short nail (HP:0001799) | 1.81622063 |
| 128 | Vascular tortuosity (HP:0004948) | 1.80820702 |
| 129 | Abnormality of the lumbar spine (HP:0100712) | 1.80455196 |
| 130 | Hypotension (HP:0002615) | 1.80214383 |
| 131 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.80166743 |
| 132 | Dicarboxylic aciduria (HP:0003215) | 1.80166743 |
| 133 | Long toe (HP:0010511) | 1.79671045 |
| 134 | Cardiovascular calcification (HP:0011915) | 1.79654729 |
| 135 | Elevated alkaline phosphatase (HP:0003155) | 1.79628747 |
| 136 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79237066 |
| 137 | Hypokalemic alkalosis (HP:0001949) | 1.79236296 |
| 138 | Widely patent fontanelles and sutures (HP:0004492) | 1.78854807 |
| 139 | Palmoplantar hyperkeratosis (HP:0000972) | 1.78036641 |
| 140 | Abnormal cartilage morphology (HP:0002763) | 1.77607313 |
| 141 | Rhinitis (HP:0012384) | 1.76991416 |
| 142 | Hypercholesterolemia (HP:0003124) | 1.76522532 |
| 143 | Abnormality of the costochondral junction (HP:0000919) | 1.76237850 |
| 144 | Abnormality of vitamin metabolism (HP:0100508) | 1.74786784 |
| 145 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74777261 |
| 146 | Arterial tortuosity (HP:0005116) | 1.74634300 |
| 147 | Vertebral hypoplasia (HP:0008417) | 1.74417105 |
| 148 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.74417105 |
| 149 | Vascular calcification (HP:0004934) | 1.73474360 |
| 150 | Mitral stenosis (HP:0001718) | 1.72907995 |
| 151 | Recurrent abscess formation (HP:0002722) | 1.72555500 |
| 152 | Increased CSF protein (HP:0002922) | 1.72469779 |
| 153 | Hand muscle atrophy (HP:0009130) | 1.72025678 |
| 154 | Increased serum pyruvate (HP:0003542) | 1.71615860 |
| 155 | Nephritis (HP:0000123) | 1.71437385 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.71133626 |
| 157 | Upper limb amyotrophy (HP:0009129) | 1.71133626 |
| 158 | Pathologic fracture (HP:0002756) | 1.69665925 |
| 159 | Abnormality of glycolysis (HP:0004366) | 1.68826695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.94788979 |
| 2 | FRK | 3.70772523 |
| 3 | EIF2AK3 | 3.40877567 |
| 4 | INSRR | 3.19428744 |
| 5 | BCKDK | 2.83876504 |
| 6 | MAPK15 | 2.79019638 |
| 7 | TAOK3 | 2.74023559 |
| 8 | BCR | 2.69271963 |
| 9 | EIF2AK1 | 2.61901791 |
| 10 | TRIB3 | 2.53137354 |
| 11 | MAP3K12 | 2.38576127 |
| 12 | MAP3K2 | 2.29970426 |
| 13 | WNK4 | 2.27267864 |
| 14 | SCYL2 | 2.17996916 |
| 15 | ERBB3 | 2.17068358 |
| 16 | SIK1 | 1.97277264 |
| 17 | FGFR4 | 1.96930969 |
| 18 | KSR2 | 1.93185007 |
| 19 | LATS1 | 1.92212886 |
| 20 | PKN2 | 1.92189180 |
| 21 | PTK6 | 1.90120869 |
| 22 | PDGFRA | 1.89967053 |
| 23 | TRIM28 | 1.88447132 |
| 24 | LMTK2 | 1.87233102 |
| 25 | MET | 1.86663211 |
| 26 | FLT3 | 1.81795223 |
| 27 | TSSK6 | 1.79425256 |
| 28 | EPHB1 | 1.70425479 |
| 29 | MST1R | 1.69519869 |
| 30 | YES1 | 1.64649808 |
| 31 | STK24 | 1.63711122 |
| 32 | PTK2 | 1.56250261 |
| 33 | MAP4K2 | 1.42414640 |
| 34 | STK38L | 1.42412704 |
| 35 | NTRK1 | 1.42013720 |
| 36 | PBK | 1.41243200 |
| 37 | FGFR3 | 1.39179517 |
| 38 | PASK | 1.38448218 |
| 39 | PIK3CG | 1.37141426 |
| 40 | FER | 1.36527757 |
| 41 | WNK3 | 1.35441482 |
| 42 | STK39 | 1.34041081 |
| 43 | TESK1 | 1.30807159 |
| 44 | TGFBR2 | 1.29943465 |
| 45 | TTK | 1.29674084 |
| 46 | CDK6 | 1.25834847 |
| 47 | EPHA2 | 1.25142483 |
| 48 | RIPK1 | 1.25105165 |
| 49 | MST4 | 1.20071170 |
| 50 | MAP3K1 | 1.17039712 |
| 51 | TIE1 | 1.16130419 |
| 52 | LRRK2 | 1.15483255 |
| 53 | EPHA3 | 1.14816058 |
| 54 | PAK3 | 1.10618604 |
| 55 | DDR2 | 1.09244318 |
| 56 | PRKG2 | 1.05968013 |
| 57 | NEK1 | 1.05736091 |
| 58 | CAMKK2 | 1.03084508 |
| 59 | NEK9 | 1.02448883 |
| 60 | SRPK1 | 1.01887789 |
| 61 | AKT3 | 1.01383877 |
| 62 | RET | 0.99973893 |
| 63 | HIPK2 | 0.98871610 |
| 64 | FGFR2 | 0.97848266 |
| 65 | KDR | 0.97509418 |
| 66 | DYRK1B | 0.96041027 |
| 67 | PDK4 | 0.94374787 |
| 68 | PDK3 | 0.94374787 |
| 69 | MAPKAPK3 | 0.91942381 |
| 70 | CSNK1G3 | 0.91741163 |
| 71 | OXSR1 | 0.90237408 |
| 72 | BMPR2 | 0.89943890 |
| 73 | MAP2K1 | 0.89814939 |
| 74 | CLK1 | 0.88804830 |
| 75 | TTN | 0.88644876 |
| 76 | CSNK1G1 | 0.88356778 |
| 77 | MAP2K2 | 0.87827578 |
| 78 | TAOK1 | 0.83056323 |
| 79 | EPHB2 | 0.81830409 |
| 80 | CSNK1A1L | 0.79612063 |
| 81 | SIK3 | 0.79339591 |
| 82 | ERBB4 | 0.78567966 |
| 83 | JAK2 | 0.78326031 |
| 84 | MAP3K3 | 0.77635699 |
| 85 | PRKD3 | 0.77409129 |
| 86 | PLK2 | 0.72149668 |
| 87 | MAP3K14 | 0.72044314 |
| 88 | MAP3K5 | 0.71680121 |
| 89 | CSNK1G2 | 0.71208103 |
| 90 | PAK2 | 0.71005239 |
| 91 | FGR | 0.69225764 |
| 92 | PAK4 | 0.68768150 |
| 93 | MAP3K6 | 0.68603474 |
| 94 | MATK | 0.68412829 |
| 95 | NEK6 | 0.67370459 |
| 96 | FGFR1 | 0.64060639 |
| 97 | JAK3 | 0.63023473 |
| 98 | PDK2 | 0.62532803 |
| 99 | CSK | 0.62126950 |
| 100 | JAK1 | 0.60689117 |
| 101 | LIMK1 | 0.60217038 |
| 102 | RPS6KA4 | 0.58842807 |
| 103 | MAPK11 | 0.57158505 |
| 104 | NLK | 0.56763588 |
| 105 | IRAK1 | 0.56538480 |
| 106 | IGF1R | 0.55990128 |
| 107 | STK10 | 0.55824362 |
| 108 | ITK | 0.54556750 |
| 109 | MOS | 0.54460583 |
| 110 | PDGFRB | 0.54101018 |
| 111 | PRKCE | 0.53964307 |
| 112 | CAMK1D | 0.53621239 |
| 113 | GSK3A | 0.51624369 |
| 114 | PRKAA2 | 0.51560200 |
| 115 | MAP3K13 | 0.50912850 |
| 116 | NUAK1 | 0.50782655 |
| 117 | MYLK | 0.49428500 |
| 118 | BLK | 0.48082840 |
| 119 | TYK2 | 0.45179843 |
| 120 | MELK | 0.44705354 |
| 121 | EGFR | 0.42497505 |
| 122 | KSR1 | 0.42198468 |
| 123 | TGFBR1 | 0.40530860 |
| 124 | TRPM7 | 0.40185404 |
| 125 | ARAF | 0.40006697 |
| 126 | MAP3K9 | 0.37865997 |
| 127 | PDPK1 | 0.36730507 |
| 128 | TBK1 | 0.35134895 |
| 129 | PRKCI | 0.34942462 |
| 130 | PRKCH | 0.34727154 |
| 131 | MAP3K8 | 0.34706473 |
| 132 | BRSK2 | 0.34097238 |
| 133 | CSF1R | 0.33828522 |
| 134 | PRKAA1 | 0.33523750 |
| 135 | DMPK | 0.33169134 |
| 136 | PRKD1 | 0.32996167 |
| 137 | ROCK1 | 0.31808313 |
| 138 | STK3 | 0.30775933 |
| 139 | ERBB2 | 0.30584882 |
| 140 | ACVR1B | 0.30238987 |
| 141 | PLK3 | 0.29777968 |
| 142 | SRC | 0.28982633 |
| 143 | PIM2 | 0.28565752 |
| 144 | TESK2 | 0.22558654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.61878916 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.34989120 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.97995357 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.68590452 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.67183993 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44757420 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.40544010 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20510871 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.04199326 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.02505801 |
| 11 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.93055357 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84972362 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84267979 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.81366745 |
| 15 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.80579646 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.78526411 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78400202 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78256819 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.77662789 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77603169 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.75453101 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.65454102 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.64051581 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.62244356 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.60567084 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.57344023 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.54874196 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52248197 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50880437 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48166054 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.46489879 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.39078754 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37655157 |
| 34 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25914867 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19790654 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12635542 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11412104 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08605483 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07945399 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04827269 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.04665177 |
| 42 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.04442615 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00058625 |
| 44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99402462 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.98559951 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98397931 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 0.96250170 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95221216 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94518007 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.93871852 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93692576 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92812930 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91368666 |
| 54 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86828442 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.83596556 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83008033 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81219218 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.80300619 |
| 59 | Other glycan degradation_Homo sapiens_hsa00511 | 0.79194789 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77483304 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76048568 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76028936 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75997020 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.75885153 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74900276 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74064266 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73089628 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71245765 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70723702 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70549330 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.70485923 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69381162 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68177382 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68062144 |
| 75 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67950330 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.67663511 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67063945 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66730337 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66363556 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65860490 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65534619 |
| 82 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63610450 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63447939 |
| 84 | Proteasome_Homo sapiens_hsa03050 | 0.61777662 |
| 85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60158020 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.59166986 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.58823381 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.56389028 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | 0.55489300 |
| 90 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54347923 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54341448 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54339249 |
| 93 | Lysine degradation_Homo sapiens_hsa00310 | 0.53360601 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51673848 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51642669 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49098568 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49033463 |
| 98 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48513563 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.48002895 |
| 100 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47656050 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47101032 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46777077 |
| 103 | Insulin secretion_Homo sapiens_hsa04911 | 0.43634386 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.42258666 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41947235 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.39470042 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.39290622 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.35851590 |
| 109 | Tuberculosis_Homo sapiens_hsa05152 | 0.35263043 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34672655 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.33673418 |
| 112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.33611801 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33281356 |
| 114 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.32852462 |
| 115 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32300933 |
| 116 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30902516 |
| 117 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30096335 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29628766 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27698376 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27485299 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27361359 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26097253 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24079634 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23640348 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.22971154 |

